Cosfez TR 150 mg+0.5 mg+61.8 mg | INDICATIONS AND USES

This preparation is indicated for the treatment and prophylaxis of Iron, Folic Acid and Zinc deficiency especially during pregnancy and lactation.

Cosfez TR 150 mg+0.5 mg+61.8 mg | DOSAGE & ADMINISTRATION

Adult or Elderly: 1 capsule daily. In more severe cases, 2 capsules daily may be required.Children: Aged over 1 year: 1 capsule daily. The capsule may be opened and the pellets to be mixed with soft cool food, but they must not be chewed.

Cosfez TR 150 mg+0.5 mg+61.8 mg | SIDE EFFECTS

Dark stools are usual during iron therapy and nausea and other symptoms of gastrointestinal irritation such as anorexia, vomiting, discomfort, constipation and diarrhoea are sometimes encountered. Zinc may also produce a gastrointestinal upset. These timed-release capsules are designed to reduce the possibility of gastrointestinal irritation. There have been rare reports of allergic reactions

Cosfez TR 150 mg+0.5 mg+61.8 mg | USE DURING PREGNANCY AND LACTATION

Use of any drug during the first trimester of pregnancy should be avoided if possible. Thus administration of Iron during the first trimester requires definite evidence of Iron deficiency where inadequate diet calls for supplementary Zinc and Folic acid is justified during the remainder of the pregnancy.

Cosfez TR 150 mg+0.5 mg+61.8 mg | PRECAUTIONS & WARNINGS

Care should be taken in patients who may develop Iron overloads, such as those with haemochromatosis, haemolytic anaemia or red cell aplasia. Failure to respond to treatment may indicate other causes of anaemia and should be further investigated. Iron & Zinc chelate with tetracycline and absorption of all three agents may be impaired. The absorption of Zinc may be reduced in the presence of Iron. Absorption of Iron may be impaired by penicillamine and by antacids. Such potential interactions can be reduced by separating the administration of each product by several hours. In patients with renal failure a risk of Zinc accumulation could exist.